Pilot Trial of Supplemental Vitamin A and Nicotinamide

Recruiting now · Early Phase 1 · Has a placebo group

Conditions studied: Skin Cancer, Kidney Transplant Recipients

In brief

The goal of this clinical trial is to assess the feasibility and safety of oral nicotinamide (NAM; a derivative of vitamin B3 \[niacin\]) and vitamin A in a high-risk population of kidney transplant recipients with a history of skin cancer to generate preliminary data for future cancer prevention clinical trials.

Key facts

Study ID
NCT05702398
Run by
Rhode Island Hospital
People needed
30
Starts
2023-04-01
Expected to finish
2028-03-01
Last updated by the study team
2026-03-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.